copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
WHO Drug Information About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
Microsoft Word - causality Website. doc For drug-drug interactions the WHO-UMC system can be used by assessing the actor drug, which influences the kinetics or dynamics of the other drug (which has usually been taken over a longer period), in the medical context of the patient
Defined Daily Dose (DDD) - World Health Organization (WHO) Drug consumption can be expressed in cost, number of units, number of prescriptions or by the physical quantity of drugs However these variables can vary between regions and countries over time This limits comparisons of drug consumption at an international level To address this, a technical unit of measurement, the Defined Daily Dose (DDD) was created
Anatomical Therapeutic Chemical (ATC) Classification In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties Drugs are classified in groups at five different levels
Health products policy and standards Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain
ECP PR - World Health Organization (WHO) For finished drug products, the sampling procedure should take ac-count of the official and non-official tests required for the individual dosage form (e g tablets or parenteral preparations) Non-official tests could include testing for adulteration and counterfeiting
General guidance on hold‑time studi 1 Introduction and background Manufacturers should ensure that the products that they manufacture are safe, efective and of the quality required for their intended use Systems should be in place to ensure that pharmaceutical products are produced according to validated processes and to defined procedures Manufacturing processes should be shown to be capable of consistently manufacturing
Annex 1 - World Health Organization (WHO) Note: For further guidance on validation of data-processing equipment, refer to documents published by the International Society for Pharmaceutical Engineering (13, 14), US Food and Drug Administration (15), European Commission (16) and the Offi cial Medicines Control Laboratories Network of the Council of Europe (17)
Annex 6 - World Health Organization (WHO) Guidance for industry Sterile drug products produced by aseptic processing Japan, 2005 Manufacture of sterile medicinal products In: The rules governing medicinal products in the European Union Vol 4 EU guidelines to good manufacturing practice medicinal products for human and veterinary use Annex 1, Brussels, 2008
WHO TB guidelines: recent updates The handbook aims to facilitate the implementation of WHO guidelines by countries, technical partners and others involved in managing patients with TB and drug-resistant TB It provides practical information on new and existing tests recommended by WHO and model diagnostic algorithms